Home » Authors » David N. Leff

Articles by David N. Leff

From the Lab: Embryonic cells create heart-like muscle cells

Sep. 1, 2001

By David N. Leff

From the Lab: Antistroke compound is proven in animals

Aug. 1, 2001

By David N. Leff

From the Lab: Zebrafish larvae point to curbing cholesterol

July 1, 2001

By David N. Leff

Penn scientists plumb depths of protection against stroke, CVD

April 2, 2001

By David N. Leff

From the Lab: Arteries injured by stents are fixed, in pigs, by gene therapy

Dec. 1, 2000

By David N. Leff

Heparin's oddball molecular structure yields to analytical tool

Nov. 1, 2000

By David N. Leff

Pregnancy-induced hypertension caused by mutant hormone

Aug. 1, 2000

By David N. Leff

Peptide blocking of clotting cascade points to thrombosis therapy

May 1, 2000

By David N. Leff

'Stunned myocardium' syndrome is traced to reaction of protein

March 1, 2000

By David N. Leff

Triple-Threat HIV-Inhibiting Regimen Allows Virus-Battered Immune System To Regenerate

May 10, 1999

By David N. Leff

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...